Early clinical experience of cell-free DNA-based aneuploidy screening: A survey of obstetric sonologists in Australia and New Zealand

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 55, Issue 2, 2015, Pages 138-143

  Hui, Lisa ^a,b,c   Teoh, Mark ^d   Piessens, Sofie ^e,f   Walker, Susan P ^a,b  

^a MERCY HOSPITAL FOR WOMEN   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d MONASH MEDICAL CENTRE   (Australia)

^e Monash Ultrasound for Women   (Australia)

^f Camberwell Ultrasound for Women ^*  (Australia)

Author keywords

cell free DNA; clinical implementation; Down syndrome; mass screening; non invasive prenatal testing

Indexed keywords

ANEUPLOIDY; ARTICLE; AUSTRALIA AND NEW ZEALAND; CELL FREE SYSTEM; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DNA DETERMINATION; E-MAIL; FEMALE; FETUS ECHOGRAPHY; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PERSONNEL ATTITUDE; HIGH RISK PREGNANCY; HUMAN; LOW RISK POPULATION; MEDICAL PERSONNEL; NON INVASIVE PRENATAL TESTING; OBSTETRIC SONOLOGIST; OBSTETRICIAN; PERSONAL EXPERIENCE; PREDICTION; PREECLAMPSIA; PREGNANCY OUTCOME; PRENATAL SCREENING; PRIORITY JOURNAL; SEX CHROMOSOME ABERRATION; AUSTRALIA; BLOOD; DOWN SYNDROME; ECHOGRAPHY; ECONOMICS; ETHICS; GYNECOLOGY; HEALTH CARE DELIVERY; NEW ZEALAND; OBSTETRICS; PREGNANCY; PRIVATE PRACTICE; PROCEDURES; QUESTIONNAIRE; SPECIALIZATION; STATISTICS AND NUMERICAL DATA; UTILIZATION;

DNA;

ANEUPLOIDY; AUSTRALIA; CELL-FREE SYSTEM; DNA; DOWN SYNDROME; FEMALE; GENETIC TESTING; GYNECOLOGY; HEALTH SERVICES ACCESSIBILITY; HUMANS; NEW ZEALAND; OBSTETRICS; PREGNANCY; PRIVATE PRACTICE; SPECIALIZATION; SURVEYS AND QUESTIONNAIRES; ULTRASONOGRAPHY; ULTRASONOGRAPHY, PRENATAL;

EID: 84928798585     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/ajo.12306     Document Type: Article

References (17)

1. Gil MM, Akolekar R, Quezada MS, et al,. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. Fetal Diagn Ther 2014; 35: 156-173.
2. Haymon L, Simi E, Moyer K, et al,. Clinical implementation of noninvasive prenatal testing among maternal fetal medicine specialists. Prenat Diagn 2014; 34: 416-423.
3. Platt LD, Janicki MB, Prosen T, et al,. Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States. Am J Obstet Gynecol 2014; 211: 368.e1-7.
4. Jaques AM, Collins VR, Mugglie EE, et al,. Uptake of prenatal diagnostic testing and the effectiveness of prenatal screening for Down syndrome. Prenat Diagn 2010; 30: 522-530.
5. American College of Obstetricians and Gynecologists Committee Opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012; 120: 1532-1534.
6. Benn P, Borell A, Chiu R, et al,. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2013; 33: 622-629.
7. Hui L, Hyett J,. Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia. Aust N Z J Obstet Gynaecol 2013; 53: 416-424.
8. Annual Report. Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2013. [Accessed 29 August 2014.] Available from URL: https://www.ranzcog.edu.au/ranzcog-annualreport.html
9. Hui L, Teoh M, da Silva Costa F, et al,. Clinical implementation of cell-free DNA based aneuploidy screening: perspectives from a national audit. Ultrasound Obstet Gynecol 2015; 45 (1): 10-15.
10. O'Leary P, Maxwell S, Murch A, Hendrie D,. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies. Aust N Z J Obstet Gynaecol 2013; 53: 425-433.
11. Bianchi DW, Parker RL, Wentworth J, et al,. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014; 370: 799-808.
12. Nicolaides KH, Syngelaki A, Ashoor G, et al,. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012; 207: 374.e371-374.e376.
13. Norton ME, Jacobsson B, Swamy G, et al,. Non-invasive examination of trisomy using directed cell-free DNA analysis: the NEXT study. Prenat Diagn 2014; 34 (Suppl 1): e1-e9.
14. Pergament E, Cuckle H, Zimmermann B, et al,. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol 2014; 124: 210-218.
15. Society of Maternal Fetal Medicine Statement: Maternal Serum Cell-Free DNA Screening in Low Risk Women. [Accessed 29 August 2014.] Available from URL: http://www.smfm.org/publications/157-smfm-statement-maternal-serum-cell-free-dna-screening-in-low-risk-women
16. Musci TJ, Fairbrother G, Batey A, et al,. Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice. Prenat Diagn 2013; 33: 424-428.
17. Salomon LJ, Alfirevic Z, Audibert F, et al,. ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice. Ultrasound Obstet Gynecol 2014; 44: 122-123.